Myeloproliferative neoplasm: Difference between revisions
No edit summary |
|||
Line 6: | Line 6: | ||
ICD10 = {{ICD10|D|47|1|d|37}} | | ICD10 = {{ICD10|D|47|1|d|37}} | | ||
ICD9 = {{ICD9|205.1}}, {{ICD9|238.4}}, {{ICD9|289.89}}, {{ICD9|289.9}} | | ICD9 = {{ICD9|205.1}}, {{ICD9|238.4}}, {{ICD9|289.89}}, {{ICD9|289.9}} | | ||
ICDO = | ICDO = | | ||
OMIM = | | OMIM = | | ||
DiseasesDB = | | DiseasesDB = | |
Revision as of 19:52, 21 September 2012
Template:DiseaseDisorder infobox
Myeloproliferative Neoplasm Microchapters |
Differentiating myeloproliferative neoplasm from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Myeloproliferative neoplasm On the Web |
American Roentgen Ray Society Images of Myeloproliferative neoplasm |
Directions to Hospitals Treating Myeloproliferative neoplasm |
Risk calculators and risk factors for Myeloproliferative neoplasm |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myeloproliferative disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies